Skip to content

Text Message (SMS) to Help Cancer Patients in Chemotherapy Treatment

An Intervention Based on Text Message (SMS) to Help Cancer Patients in Chemotherapy Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03087422
Enrollment
80
Registered
2017-03-22
Start date
2016-08-01
Completion date
2017-12-15
Last updated
2017-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Side Effect

Brief summary

This study evaluates the text message (SMS) with orientation to help the management of chemotherapy treatment.

Detailed description

The investigators developed an app (called ChemotherApp) for Android that automatically sends text messages with homecare orientation to cancer patients in intervention group. The main features of this app are: to register information such as name, number of cellphone, gender, and chemotherapy schedule of the patient. Other feature is to register the orientation that will be sent to patients by text messages. Daily, the app send a registered orientation to each patient.

Interventions

The intervention consists in sending text messages with orientation that helps in homecare, specifically attempting to minimize chemotherapy side effects.

Sponsors

Samanta Winck Madruga
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Cancer patients who will start chemotherapy treatment in Hospital Escola of Federal University of Pelotas.

Exclusion criteria

* Illiterate patients; Patients who do not have their own cell phone

Design outcomes

Primary

MeasureTime frameDescription
Change from Chemotherapy Side Effects - QLQ-C30 EORTC questionnaireUp to 4 monthTo measure the side effects, the QLQ-C30 EORTC questionnaire is going to be used. This questionnaire aims to identify if the patient had nausea and vomit, diarrhea, pain, fever, constipation, diarrhea, gas, among other symptoms. It will be investigated if patients who will receive the text message will have less side effects than patients who will not receive text messages. The questionnaire will be applied to each patient in the study at the beginning of the second,third and fourth cycles of chemotherapy.

Secondary

MeasureTime frameDescription
Change from Anxiety and Depression - HADS (Hospital Anxiety and Depression Scale) questionnaireUp to 4 monthTo measure anxiety and depression, the HADS (Hospital Anxiety and Depression Scale) questionnaire is going to be used. It will be investigated if patients who will receive the text message will have less score of depression and anxiety than patients who will not receive text messages. The HADS questionnaire is going to be applied to each patient on the first day of treatment and at the beginning of the fourth cycle of chemotherapy.

Other

MeasureTime frameDescription
Change from ECOG (The Eastern Cooperative Oncology Group) scale - performance status - well-beingUp to 4 monthECOG (The Eastern Cooperative Oncology Group) scale will be used to evaluate the performance status,to measure the well-being. It will be investigated if patients who will receive the text message will have better performance status than patients who will not receive text messages. A performance status will be evaluated at the beginning of treatment and at the beginning of the second cycle of chemotherapy.

Countries

Brazil

Contacts

Primary ContactSamanta Madruga, Dr.
ensino@heufpel.com.br55533284-4900
Backup ContactTimoteo Rico
timoteomr@gmail.com555332739073

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026